AIToday
AI Coding AssistantsTop Companies' AI MovesAI Business & IndustryTop Companies AIPublished: Oct 7, 2026, 06:31 JST

Cognizant, Gilead extend DevOps and AI deal for five years

Cognizant, Gilead extend DevOps and AI deal for five years

3 Key Points

  1. What happened

    Cognizant announced a five-year extension of its work with Gilead Sciences to support the biopharmaceutical company's DevOps capabilities and responsible application of agentic AI tools across selected technology programs.

  2. Why it matters

    The deal builds on more than a decade of Cognizant supporting Gilead's global IT infrastructure, platforms, applications and advanced analytics, and signals Gilead's intent to evaluate practical, responsible AI uses across its technology environment.

  3. What to watch

    The work is expected to focus on practical use cases intended to simplify processes and improve delivery; the test is whether these selected programs yield operational efficiency for Gilead's teams.

WHO IT HITSThis affects IT leaders and technology operations teams at biopharma companies who are weighing how to adopt agentic AI (AI tools that can take actions on their own) in regulated environments, as well as the vendors that support them.

Not sure about something? Ask the AI

Questions and answers are published on this page.

Summaries like this, in your inbox every morning.

Context & Analysis

The agreement extends a relationship that already spans more than a decade, during which Cognizant has supported elements of Gilead's global IT infrastructure, platforms, applications and advanced analytics. The updated scope adds support for selected DevOps and AI-enabled capabilities, building on that existing foundation rather than starting from scratch.

The focus on agentic AI tools—AI that can carry out tasks with some autonomy—is notable in a biopharmaceutical context, where Gilead says it is evaluating practical, responsible uses across its technology environment while maintaining its broader mission to deliver for patients. Cognizant's stated role is to bring together life sciences experience, DevOps capabilities and AI tools to help improve delivery across selected programs.

How much of an impact this has will hinge on whether the selected programs actually simplify processes and improve delivery, as the work is expected to focus on practical use cases. For Gilead, the payoff would be more efficient execution of priority technology programs; for Cognizant, it reinforces its positioning in life sciences technology services.

FAQ
How long is the Cognizant-Gilead agreement?
The agreement is a five-year extension of Cognizant's existing work with Gilead Sciences.
What will Cognizant do for Gilead under the new agreement?
Cognizant will support Gilead's continued development of DevOps capabilities and the responsible application of agentic AI tools across selected technology programs.
Who commented on the agreement from Gilead and Cognizant?
Anna Berg Asberg, Global CIO at Gilead, and Surya Gummadi, President, Americas at Cognizant, provided comments on the agreement.
Top Companies AIRead Original Article

AI news that matters for your work, delivered every morning.

Pick your industry and the AI tools you use, and get news related to your work every day.

Free · 30 seconds with Google · unsubscribe anytimeWhat is AIToday? →

Ask AI

Ask AI anything about this article. The AI reads this article, earlier AIToday articles, and Wikipedia, and cites its sources. Q&As are published on this page for other readers too.

Questions and answers are published on this page.

Related Articles

Next articleDaiwa House CVC backs US industrial humanoid maker Persona AI